Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extended-spectrum beta-lactamases.

Jan E Patterson1

  • 1Department of Medicine (Infectious Diseases), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, USA. pattersonj@uthscsa.edu

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SHEA/APIC/IDSA/PIDS multisociety position paper: Raising the bar: necessary resources and structure for effective healthcare facility infection prevention and control programs - CORRIGENDUM.

Infection control and hospital epidemiology·2025
Same author

SHEA/APIC/IDSA/PIDS multisociety position paper: Raising the bar: necessary resources and structure for effective healthcare facility infection prevention and control programs.

Infection control and hospital epidemiology·2025
Same author

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.

JAMA·2023
Same author

Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy.

Prostate international·2022
Same author

Essential Oils Can Mitigate Adverse Effects of Prolonged Masking in the Hospital Setting.

Holistic nursing practice·2022
Same author

The Clinical Safety and Effectiveness Course: Ten Years of Experiential Training in Quality Improvement for Practicing Professionals.

American journal of medical quality : the official journal of the American College of Medical Quality·2021
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Extended-spectrum beta-lactamases (ESBLs) in Klebsiella pneumoniae and Escherichia coli are a growing global threat, especially in ICUs. Controlling ESBL spread requires robust infection control and judicious antibiotic use.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Extended-spectrum beta-lactamases (ESBLs) are increasingly prevalent, particularly in Klebsiella pneumoniae and Escherichia coli.
  • ESBL-producing organisms pose a significant challenge in intensive care units (ICUs) globally, with higher rates in Latin America and Asia.

Purpose of the Study:

  • To review the epidemiology and resistance patterns of ESBL-producing bacteria.
  • To highlight the challenges in treating infections caused by these multidrug-resistant organisms.
  • To emphasize the importance of prevention and control strategies.

Main Methods:

  • Literature review of studies on ESBL prevalence and resistance.
  • Analysis of antimicrobial resistance mechanisms and patterns.

Related Experiment Videos

  • Discussion of clinical implications and control strategies.

    • Main Results:

    • ESBLs confer resistance to multiple antibiotics, including cephalosporins and aztreonam.
    • Co-resistance to aminoglycosides, trimethoprim/sulfamethoxazole, and fluoroquinolones is common.
    • Carbapenems remain a primary treatment option, but their overuse may lead to further resistance.

    Conclusions:

    • Limited therapeutic options necessitate stringent infection control measures, including contact precautions in ICUs.
    • Antibiotic stewardship programs are crucial for limiting the spread of ESBLs by optimizing antibiotic utilization.